№ lp_2_1_19481
File format: docx
Character count: 10992
File size: 25 KB
Patient information leaflet detailing composition, indications, contraindications, administration, storage, and safety of Grippol® Quadrivalent influenza vaccine.
Year:
2026
Region / City:
Russian Federation
Type:
Patient information leaflet
Product:
Grippol® Quadrivalent
Therapeutic group:
Vaccine against influenza (inactivated) with adjuvant
Dosage form:
Solution for intramuscular and subcutaneous injection
Active ingredients:
Influenza virus antigens A(H1N1), A(H3N2), B Yamagata, B Victoria, Azoximer bromide
Indications:
Influenza prophylaxis for children over 6 years, adolescents, adults under 60 years, high-risk and occupational groups
Contraindications:
Allergy to chicken proteins or vaccine components, age under 6, pregnancy (for preservative-containing vaccine), acute illness
Administration:
Intramuscular or deep subcutaneous injection, 0.5 ml per dose, annual vaccination
Storage conditions:
2–8 °C, protect from contamination, follow aseptic rules
Regulatory status:
Marketing authorization in Russia
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2014-2015
Region / City:
United States
Topic:
Influenza Vaccination
Document Type:
Informational Guide
Organization / Institution:
Centers for Disease Control and Prevention (CDC)
Author:
[xxx]
Target Audience:
Pharmacists, Healthcare Providers, Retailers
Period of Validity:
Current influenza season
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2019
Region / City:
Australia
Topic:
Influenza Vaccination
Document Type:
Application for Immunization Program Listing
Organization / Institution:
Seqirus (Australia) Pty Ltd
Author:
Seqirus (Australia) Pty Ltd
Target Audience:
Health policymakers, healthcare providers
Period of Validity:
Ongoing
Approval Date:
2019
Amendment Date:
N/A
Year:
2016
Region / City:
Australia
Topic:
Influenza Vaccination
Document Type:
Regulatory Submission
Organ / Institution:
PBAC, TGA
Author:
Seqirus
Target Audience:
Healthcare professionals, regulatory bodies
Period of Validity:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Clinical Trials:
Yes
Main Comparator:
Fluarix® Tetra
Outcome:
Non-inferiority of Afluria® Quad
Context:
The document outlines the submission and evaluation of Afluria® Quad for listing on the National Immunisation Program in Australia, comparing it with existing vaccines.
Year:
2024
Region / city:
Barnet
Topic:
EBSA (Emotional Based School Avoidance)
Document type:
Guidance
Institution:
Partnership for Jewish Schools (PaJeS)
Author:
Sinéad O’Callaghan, Kim Miller, Lisa Coffman, Julia Alberga, Jessica Overlander-Kaye, Abigail Freedman, Bracha Hackner, Caron Aspis, Daniel Weisberg, Hannah Martin, Julia Silver, Keren Greene, Naomi Simon, Samantha Cohen, Sara Levan, Sarah Bronzite, Sasha Sharpe, Sophie Driver, Shiri Lader, Suzanne Jaeger, William Hemens
Target audience:
Families and professionals supporting children experiencing EBSA in Jewish schools
Action period:
2024 onwards
Approval date:
2024
Modification date:
Not specified
Note:
Year
Topic:
Data protection, research ethics, participant consent
Document Type:
Template
Target audience:
Researchers conducting non-health-related studies involving personal data
Organisation:
Odiham and Old Basing Health Centres
Type of document:
Patient leaflet
Region:
Hampshire, England
Healthcare system:
NHS
Facilities:
Odiham Health Centre; Old Basing Health Centre
Services covered:
General practice; primary care; community health services
Opening hours:
Monday–Friday
Appointment system:
Telephone triage; face-to-face appointments; online booking
Out-of-hours care:
NHS 111
Emergency contact:
999
Training status:
GP training practice
Patient engagement:
Patient Participation Group
Document audience:
Registered patients and prospective patients
Document purpose:
Patient information and service overview
Contact details included:
Telephone; email; website
Accessibility information:
Parking; disabled access; wheelchair availability
Note:
Year
Region / City:
Barrow in Furness, Cumbria
Subject:
Healthcare Services
Document Type:
Information Leaflet
Organization:
Duke Street Surgery
Target Audience:
Patients of Duke Street Surgery
Context:
A leaflet detailing the healthcare services offered by Duke Street Surgery, including appointments, prescriptions, and various medical services.
Year:
2023
Region / City:
Tallaght, Dublin
Topic:
Research Ethics, Data Protection
Document Type:
Template
Organization:
St James’s Hospital / Tallaght University Hospital
Author:
Joint Research Ethics Committee
Target Audience:
Researchers, Adult Participants, Patients, Parents, Carers
Period of Validity:
N/A
Approval Date:
N/A
Date of Last Update:
N/A
Document No:
FDA/DNC/TEM-02
Date of First Adoption:
1st February 2013
Date of Issue:
8th January 2024
Version No:
03
Issuing Authority:
Food and Drugs Authority, Ghana
Acknowledgement:
World Health Organization (WHO)
Type of Document:
Patient Information Leaflet (PIL)
Target Audience:
Patients and healthcare providers
Content:
Instructions, warnings, side effects, storage, and pharmaceutical information of the medicine
Year:
2019
Regulation:
EU 2019/6
Document type:
Guidance template
Author:
European Union
Target audience:
Applicants of veterinary medicinal products
Approval date:
Not specified
Modification date:
Not specified
Description:
Template for packaging label and leaflet for veterinary medicinal products intended to be included on the immediate packaging, as outlined by EU regulation.
Note:
Year
Topic:
Data Protection, Research Ethics
Document Type:
Guidance
Institution:
Trinity College Dublin
Author:
Trinity College Dublin Data Protection Office
Target Audience:
Researchers
Year:
2023
Region / City:
Ireland
Subject:
Health research, Data protection
Document type:
Guidance document
Institution:
Trinity College Dublin
Author:
Data Protection Office
Target audience:
Researchers conducting health research
Period of validity:
Not specified
Approval date:
Not specified
Date of amendments:
Not specified
Year:
2023
Region / city:
Global
Topic:
Pharmaceutical Information
Document Type:
Patient Information Leaflet (PIL)
Organization / Institution:
World Health Organization (WHO)
Author:
WHO Prequalification Team
Target Audience:
Patients, healthcare providers
Validity Period:
Not specified
Approval Date:
Not specified
Date of Amendments:
Not specified
Year:
2021
Region / city:
UK
Topic:
Health
Document Type:
Leaflet
Organization:
Public Health England, NHS
Author:
Public Health England
Target Audience:
General public, people with vitamin D deficiency, vulnerable groups, pregnant and breastfeeding women
Period of Validity:
Autumn and Winter months
Date of Approval:
Not specified
Date of Amendments:
Not specified
Year:
2023
Region / city:
United Kingdom
Topic:
Diet / Nutrition
Document Type:
Patient Information Leaflet
Organization / Institution:
Health Service
Author:
Speech and Language Therapist, Dietitian
Target Audience:
Patients, relatives, caregivers
Effective Date:
2023
Modification Date:
None specified
Year:
2021
Region / City:
Bilbrook
Topic:
Contraception
Document Type:
Patient Information Leaflet
Organization / Institution:
Bilbrook Medical Centre
Author:
Bilbrook Medical Centre
Target Audience:
Patients using Sayana® Press
Duration:
13 weeks
Approval Date:
May 2021
Review Date:
May 2023
Changes Date:
N/A